Related Experiment Video
Updated: May 2, 2026

In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites
R N Baldassano1, S Schreiber, R B Johnston
1Division of Gastroenterology, Children's Hospital of Philadelphia, Pennsylvania.
Background:
Inflammatory bowel disease occurs in regions of the intestine characterized by a bowel content high in bacteria. Intestinal bacteria synthesize cell wall products such as lipopolysaccharide; when normal monocytes or macrophages come in contact with these products, they can be primed to release a number of inflammatory mediators. Mediators such as toxic oxygen metabolites released as part of the respiratory burst may contribute to inflammatory tissue damage. The aim of this study was to determine if monocytes from patients with Crohn's disease are primed by lipopolysaccharide for a greater respiratory burst.
Methods:
The generation of superoxide anion was measured by superoxide dismutase inhibitable reduction of ferricytochrome c.
Results:
Freshly isolated monocytes from active untreated Crohn's disease patients (n = 8) showed enhanced stimulated release of superoxide anion when compared with normal monocytes (n = 15; 3.80 +/- 0.12 vs. 1.02 +/- 0.06 nmol/5 min; P < 0.001). We tested the hypothesis that the monocyte priming factor in Crohn's disease serum may be lipopolysaccharide by showing that Crohn's disease serum lost its ability to prime normal monocytes after lipopolysaccharide was removed (0.25 +/- 0.25 nmol/5 min, P < 0.001).
Conclusions:
These studies indicate that bacterial cell wall products may be important proinflammatory molecules involved in the initiation and/or perpetuation of Crohn's disease.
Insights
Monocytes from Crohn's disease patients exhibit heightened inflammatory responses due to bacterial products like lipopolysaccharide. This suggests bacterial cell wall components may drive inflammatory bowel disease progression.
Area of Science:
- Immunology
- Gastroenterology
Background:
- Inflammatory bowel disease (IBD) is linked to high bacterial loads in the intestine.
- Bacterial products, such as lipopolysaccharide (LPS), can prime immune cells (monocytes/macrophages).
- Primed immune cells may release inflammatory mediators, contributing to tissue damage.
Purpose of the Study:
- To investigate if monocytes from Crohn's disease patients are primed by lipopolysaccharide for an exaggerated respiratory burst.
- To explore the role of lipopolysaccharide as a priming factor in Crohn's disease serum.
Main Methods:
- Monocyte superoxide anion generation was quantified using the reduction of ferricytochrome c.
- This reduction was measured in an inhibitable manner by superoxide dismutase.
- Serum from Crohn's disease patients was tested for its ability to prime normal monocytes before and after lipopolysaccharide removal.
Main Results:
- Monocytes from active, untreated Crohn's disease patients demonstrated significantly enhanced superoxide anion release compared to normal monocytes.
- Crohn's disease serum lost its capacity to prime normal monocytes after lipopolysaccharide was depleted.
- These findings strongly implicate lipopolysaccharide in the heightened monocyte response observed in Crohn's disease.
Conclusions:
- Bacterial cell wall products, like lipopolysaccharide, appear to be significant proinflammatory molecules.
- These molecules may play a crucial role in initiating or sustaining the inflammatory processes in Crohn's disease.
Related Concept Videos
Inflammation
Differentiation of Common Myeloid Progenitor Cells
Acute Inflammation I: Cellular Phase
Chronic Inflammation: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

